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DiseasesAbstract The aim of the work is to reveal the role of transthoracic ultrasound in the diagnosis of
chest diseases. Thirty one cases that had pulmonary opacities were included.
CT guided biopsy, pleural ﬂuid aspiration, thoracoscopy with pleural biopsy were done when
indicated. This study found that transthoracic ultrasound is valuable for the evaluation of a wide
variety of chest diseases, particularly when the pleural cavity is involved.
Conclusion: Transthoracic ultrasound is a feasible, safe and low cost method for diagnosis of
some chest diseases.
 2016 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
The diagnostic value of transthoracic US is limited by the
bony delimitation (ribs, spinal column, sternum, clavicles
and scapulae) and the gas content of the lung. The US
window is created by consolidation of lung parenchyma
or pleural effusion interposed between the lesion and the
chest wall, which allows the US beam to penetrate and
visualize lesions deep within the lung parenchyma. However,
US is less expensive and more convenient than computed
tomography (CT) or magnetic resonance imaging (MRl);it provides immediate information with real-time imaging,
and can give information not available from a standard
radiograph [3].
Ultrasound has been proved to be valuable for the evalua-
tion of a wide variety of chest diseases, particularly when the
pleural cavity is involved. Pleural effusion, pleural thickening,
pleural tumors, tumor extension into the pleura and even the
chest wall, pleuritis, and pneumothorax can be detected easily
and accurately with chest ultrasound. The advantages of
low-cost, bedside availability and no radiation exposure have
made ultrasound an indispensable diagnostic tool in modem
pulmonary medicine, [7].Aim of the work
This study was conducted to reveal the role of transthoracic
ultrasound in the diagnosis of chest diseases.
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The present study was conducted in Chest Department in col-
laboration with Tropical Department, Kasr EI-Aini Hospital
in the period from June 2010 to January 2011.
Study design
The present study included 31 patients who fulﬁlled the selec-
tion criteria and formed the study population. The included
patients were selected from the Chest Department inpatients,
Kasr EI-Aini Hospital.
Inclusion criteria
1. A chest radiography showing one or more opacities.
2. Presence of dullness by clinical examination over the lung
ﬁelds.
3. An acoustic window for the ultrasound beam to penetrate.
This window exists when the lesion is in direct contact with
the parietal pleura so that the ultrasound beam can propagate
through the lesion without being stopped by interopposed air.
Exclusion criteria
– Absence of an acoustic window for the ultrasound beam.
Methodology
– The included patients were subjected to the following:
(1) Written informed consent
It was obtained from each patient, including the whole
study description, the patient’s right to withdraw from
the study at any time during his or her participation.Left apical lung
(diagnosed by US guided biopsy as
Case 1The consent also included the acceptance of the patient
to use his or her data for publication and presentation
after masking his/her name.
(2) Full history taking with particular attention to mass 
 bronc– Smoking history.
– Occupational history.
– Duration of illness.
– Medication used.
– Associated illness such as diabetes or hypertension.(3) Full clinical examination.
(4) Chest X-ray
– Postero-anterior and lateral views.
– Lateral decubitus ﬁlm whenever indicated.(5) CT chest:
Also CT guided biopsy was done whenever indicated.
(6) Bleeding proﬁle:– It was done for patients who underwent any invasive
procedure.(7) Pleural effusion analysis (in cases of pleural effusion):
– The pleural ﬂuid was sent for chemical, bacteriologi-
cal and cytological examination.(8) Thoracoscopy and thoracoscopic pleural biopsies were
done whenever indicated.
(9) Transthoracic ultrasonography.
(10) Ultrasound guided aspiration of pleural ﬂuid.
Results
These are examples of some sonographic images and the
corresponding CT images of certain patients in the current
study:hogenic carcinoma) 
Anterior mediastinal mass & Rt. sided pleural effusion 
(diagnosed by open biopsy as lymphoma) 
Case 2
Exudative pleural effusion 
(it was diagnosed as metastatic adenocarcinoma) 
Case 3
Pleural nodules 
(diagnosed by thoracoscopic biopsy as mesothelioma) 
Case 4
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Area of consolidation bilaterally 
(diagnosed by US guided biopsy as pneumonia) 
Case 5
Computed tomographic scan showing right supraclavicular mass (left) and 
ultrasound shows low-density lesion (right). 
Case 6
854 H. AminDiscussion
The study was conducted in Kasr El-Aini Hospital, chest and
tropical departments in the period from June 2010 to January
2011.
It included 31 patients; there were males and females with
mean age of years. CT chest and transthoracic ultra sonogra-
phy were done in all patients. Pleural ﬂuid aspiration, analysis,
thoracoscopy and thoracoscopic pleural biopsies were done
when indicated.
In the present study (Table 4), the most frequent diagnosis
was bronchogenic carcinoma (39.2% of diagnosed patients)
and the least frequent diagnosis was tuberculosis and empyema
(3.6% of diagnosed patients). Smoking was mainly linked to
malignant diseases e.g., 45.5% of patients with bronchogenic
carcinoma and 25% of patients with mesothelioma were smok-
ers. Also all patients with lymphoma were smokers (Table 1).
This agrees with [1] who stated that tobacco smoking, espe-
cially cigarettes, has a causal role in the increase in broncho-
genic carcinoma.Pleural effusion (38.7%) and lung mass (35.5%) were the
most frequent ﬁndings detected by US in the studied patients,
followed by pleural thickening (16.1%) and mediastinal mass
(12.9%). The least detected ﬁndings were lung consolidation
(9.7%), pleural nodules (3.2%), pleural septations (3.2%)
and mediastinal lymphadenopathy (3.2%). (Table 2).
This is coinciding with the study done by [4] who stated that
ultrasonography can be used to clarify the nature of pleural
densities, pleural effusions and pleural thickening. It can also
differentiate pleural from parenchymal lesions, visualize ill
parenchyma obscured by pleural effusion and detect pleural
septations and other pleural abnormalities. It also makes the
differential diagnosis of pulmonary parenchyma diseases like
consolidation, atelectasis and tumor.
In the present study (Table 3), 16 cases out of the 31
patients (52%) of the study population were diagnosed by
US guided biopsy, 9/16 cases were diagnosed as bronchogenic
carcinoma with a percent of 56.2%, 3/16 cases were diagnosed
as pneumonia with a percent of 18.7%, 2/16 cases were diag-
nosed as lung abscess with a percent of 12.5%, 1/16 cases
Table 1 Smoking in correlation to ﬁnal diagnosis.
Diagnosis Number
of cases
Smokers Nonsmokers
Bronchogenic carcinoma 11 5 6
(45.5%) (54.5%)
Empyema 1 0 1
(0.0%) (100%)
Hepatic hydrothorax 3 1 2
(33.3%) (66.7%)
Lung abscess 2 0 2
(0.0%) (100%)
Lymphoma 2 2 0
(100%) (0.0%)
Mesothelioma 4 1 3
(25%) (75%)
Pneumonia 4 0 4
(0.0%) (100%)
Tuberculosis 1 0 1
(0.0%) (100%)
Table 2 Finding detected by US in the studied patients
(n= 31).
Frequency Percent
Pleural thickening 5 16.1
Pleural nodules 1 3.2
Pleural septations 1 3.2
Pleural eﬀusion 12 38.7
Lung consolidation 3 9.7
Lung mass 11 35.5
Cystic lesion 3 9.7
Mediastinal Lymphadenopathy 1 3.2
Mediastinal mass 4 12.9
Table 3 Number of cases diagnosed by US guided biopsy.
Frequency Percent
Bronchogenic carcinoma 9 56.2
Lung abscess 2 12.5
Lymphoma 1 6.3
Pneumonia 3 18.7
Tuberculosis 1 6.3
Total 16 100.0
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nosed tuberculosis (6.3%).
This is coinciding with the study done by [10] who used US
guided biopsy to diagnose some pulmonary lesions, 27 patients
were studied, 21 of them were diagnosed by US guided biopsy.
17/27 were diagnosed as bronchogenic carcinoma (62.9%) and
1/27 of them were diagnosed as tuberculosis (3.7%) and 3/27
of them were diagnosed as infectious inﬂammatory process
(11.1%).
In our study (Table 5) transthoracic ultrasound detected
lung consolidation in 3 patients of the study population and
CT chest conﬁrmed this ﬁnding in all of them. On the other
hand transthoracic ultrasound didn’t detect lung consolidationin 28 patients of the study population and CT chest conﬁrmed
this ﬁnding in 17 of them and disagreed with transthoracic
ultrasound in 11 patients.
The difference in this ﬁnding between transthoracic ultra-
sound and CT chest was found to be statistically insigniﬁcant.
These results agree with a study done by [2] 120 patients. A
discharge diagnosis of pneumonia was conﬁrmed in 81
(67.5%). Lung ultrasound was positive in 80/81 (sensitivity
98%) and negative in 37/39 (speciﬁcity 95%). CT scan was
performed in 30 patients (26 of which were positive for
pneumonia); in this subgroup lung ultrasound was positive
in 25/26 (sensitivity 96%). The feasibility of ultrasound was
100% and the examination was always performed in less than
5 min.
These results also agree with those of [6] who compared
chest ultrasound and chest CT in 19 patients admitted with
complicated pneumonia and parapneumonic effusion. The
authors concluded that, in this series of children with pneumo-
nia complicated by parapneumonic effusion, chest ultrasound
provided data similar to chest CT in the evaluation of pleural
ﬂuid as well as the assessment of underlying parenchymal con-
solidation, necrosis, or abscess. Chest CT did not provide any
additional clinically useful information that was not also seen
in chest ultrasound.
In this study (Table 6), transthoracic ultrasound detected
lung mass in 11 patients of the study population and CT chest
conﬁrmed this ﬁnding in 7 of them. On the other hand
transthoracic ultrasound didn’t detect lung mass in 20 patients
of the study population and CT chest conﬁrmed this ﬁnding in
13 of them and disagreed with transthoracic ultrasound in 7
patients.
The difference in this ﬁnding between transthoracic ultra-
sound and CT chest was found to be statistically insigniﬁcant.
In this study (Table 7), transthoracic ultrasound detected
cystic lesion in 3 patients of the study population and CT chest
conﬁrmed this ﬁnding in 1 of them. On the other hand
transthoracic ultrasound didn’t detect cystic lesion in 28
patients of the study population and CT chest conﬁrmed this
ﬁnding in 19 of them and disagreed with transthoracic ultra-
sound in 9 patients.
The difference in this ﬁnding between transthoracic ultra-
sound and CT chest was found to be statistically insigniﬁcant.
Normal lymph nodes are virtually invisible by ultrasonog-
raphy because they are isoechoic with respect to relatively
bright mediastinal fat. Diseased lymph nodes are mostly
hypoechoic, whether they are due to from lymphoma, meta-
static cancer, or inﬂammatory processes. After speciﬁc treat-
ment, abnormal lymph nodes shrink and become more
hyperechoic until they become invisible [8].
In this study (Table 8), transthoracic ultrasound detected
mediastinal lymphadenopathy in only 1 patient of the study
population and CT chest disagreed with US in this ﬁnding.
On the other hand transthoracic ultrasound didn’t detect medi-
astinal lymphadenopathy in patients of the study population
and CT chest conﬁrmed this ﬁnding in 20 of them and dis-
agreed with transthoracic ultrasound in 10 patients.
These results disagree with [5] who stated that lym-
phadenopathy is the most common abnormality that will be
encountered during US scanning of the mediastinum.
In this study (Table 9) transthoracic ultrasound detected
mediastinal mass in 4 patients of the study population and
CT chest conﬁrmed this ﬁnding in all of them. On the other
Table 4 Final diagnosis in correlation to method of diagnosis.
Frequency US guided
biopsy
US guided
aspiration
CT Guided
biopsy
Broncho-scopic
biopsy
Thoraco-scopic
biopsy
Openbiopsy
Bronchogenic
carcinoma
11 9 1 1
(39.2%)
Empyema 1 1
3.6%
Hepatic
hydrothorax
3 3
10.7%
Lung abscess 2 2
7.1%
Lymphoma 2 1 1
7.1%
Mesothelioma 4 1 3
14.2%
Pneumonia 4 3 1
14.2%
Tuberculosis 1 1
3.6%
Total 28 16 6 1 1 3 1
(100%) (57.1%) (21.4%) (3.6%) (3.6%) (10.7%) (3.6%)
Table 5 Assessment of lung consolidation by US in relation to CT.
Total Description of the lesions by US in relation to CT
Disagree Agree
Lung consolidation (by US) Yes Count 3 0 3
% 100% 0.0% 100%
% 9.7% 0.0% 15.0%
No Count 28 11 17
% 100% 39.3% 60.7%
% 90.3% 100% 85.0%
Total Count 31 11 20
% 100% 35.5% 64.5%
% 100% 100% 100%
P-value = 0.54 (N.S)
Table 6 Assessment of lung mass by US in relation to CT.
Total Description of the lesions by US in relation to CT
Disagree Agree
Lung mass (by US) Yes Count 11 4 7
% 100% 36.4% 63.6%
% 35.5% 36.4% 35.0%
No Count 20 7 13
% 100% 35.0% 65.0%
% 64.5% 63.6% 65.0%
Total Count 31 11 20
% 100% 35.5% 64.5%
% 100% 100% 100%
P-value = 1 (N.S)
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Table 7 Assessment of cystic lesion by US in relation to CT.
Total Description of the lesions by US in relation to CT
Disagree Agree
Lung lesion (by US) Yes Count 3 2 1
% 100% 66.7% 33.3%
% 9.7% 18.2% 5.0%
No Count 28 9 19
% 100% 32.1% 67.9%
% 90.3% 81.8% 95.0%
Total Count 31 11 20
% 100% 35.5% 64.5%
% 100% 100% 100%
P-value = 0.28 (N.S)
Table 8 Assessment of mediastinal lymphadenopathy by US in relation to CT.
Total Description of the lesions by US in relation to CT
Disagree Agree
Mediastinal Lymphadenopathy (by US) Yes Count 1 1 0
% 100% 100% 0.0%
% 3.2% 9.1% 0.0%
No Count 30 10 20
% 100% 33.3% 66.7%
% 96.8% 90.9% 100%
Total Count 31 11 20
% 100% 35.5% 64.5%
% 100% 100% 100%
P-value = 0.36 (N.S)
Table 9 Assessment of mediastinal mass by US in relation to CT.
Total Description of the lesions by US in relation to CT
Disagree Agree
Mediastinal mass (by US) Yes Count 4 0 4
% 100% 0.0% 100%
% 12.9% 0.0% 20.0%
No Count 27 11 16
% 100% 40.7% 59.3%
% 87.1% 100% 80.0%
Total Count 31 11 20
% 100% 35.5% 64.5%
% 100% 100% 100%
P-value = 0.27 (N.S)
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in 27 patients of the study population and CT chest conﬁrmed
this ﬁnding in 16 of them and disagreed with transthoracic
ultrasound in 11 patients.
The difference in this ﬁnding between transthoracic ultra-
sound and CT chest was found to be statistically insigniﬁcant.
These results disagree with those of [9] who compared CT
chest and US. There were 182 patients, of whom 134 had
mediastinal masses of various origins, including lymphoma,
lung cancer, primary mediastinal tumors, and metastases fromdistant sites. The supra-aortic, paratracheal, prevascular, and
pericardial tumors were detected by US with an average
sensitivity of 95%. Subcarinal and aortopulmonary window
lesions were somewhat more difﬁcult to see, with the sensitivity
of US being 69% and 81%, respectively. The posterior
mediastinum and paravertebral regions were poorly seen, with
6% and 11% sensitivities. In all regions, the speciﬁcity of US
was 99% or 100%. In all compartments US was superior to
CT chest, but in the paravertebral compartment CT was the
‘gold standard’.
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